FDA product code DIO: Enzyme Immunoassay, Cocaine And Cocaine Metabolites
DIO is the FDA product code for enzyme immunoassay, cocaine and cocaine metabolites. It is a Class II device, regulated under 21 CFR 862.3250 and reviewed by the Clinical Toxicology panel. FDA has cleared 145 510(k) submissions under DIO, 1 in the last five years, from 71 different applicants. The average 510(k) review took 117 days (median 80). FDA has posted 23 recalls for DIO devices.
Classification
| Field | Value |
|---|---|
| Device name | Enzyme Immunoassay, Cocaine And Cocaine Metabolites |
| Device class | Class II |
| Regulation | 21 CFR 862.3250 |
| Review panel | TX — Clinical Toxicology |
| Medical specialty | Clinical Toxicology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for DIO
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 3 | 262 |
| 2018 | 1 | 29 |
| 2020 | 1 | 267 |
| 2021 | 1 | 91 |
| 2022 | 1 | 120 |
Compare with all 510(k) review times · Search every DIO clearance
Top DIO applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Syva Co. | 9 | 2000-01-27 |
| Roche Diagnostic Systems, Inc. | 9 | 1998-12-11 |
| Princeton BioMeditech Corp. | 7 | 2002-06-10 |
| Abbott Laboratories | 6 | 2002-03-13 |
| Guangzhou Wondfo Biotech Co., Ltd. | 4 | 2016-06-27 |
66 more applicants have DIO clearances. See the full list in Caduvo.
Most recent DIO clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K213211 | Carolina Liquid Chemistries Corp. | Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System | 2022-01-27 | 120 |
| K211973 | Microgenics Corporation | DRI Cocaine Metabolite Assay | 2021-09-24 | 91 |
| K191638 | Medtest DX | Pointe Scientific Cocaine Metabolite Enzyme Immunoassay | 2020-03-12 | 267 |
| K181499 | Microgenics Corporation | DRI Cocaine Metabolite Assay | 2018-07-06 | 29 |
| K170293 | Siemens Healthcare Diagnostics, Inc. | Emit II Plus Cocaine Metabolite Assay | 2017-10-25 | 267 |
Recalls for DIO devices
23 product recalls in 11 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2020-08-18.
| Year | Recalls |
|---|---|
| 2017 | 1 |
| 2020 | 8 |
Frequently asked questions
What is FDA product code DIO?
DIO is the FDA product code for enzyme immunoassay, cocaine and cocaine metabolites. It is a Class II device, regulated under 21 CFR 862.3250 and reviewed by the Clinical Toxicology panel.
What device class is DIO?
Class II, regulation 21 CFR 862.3250. Typical premarket route: 510(k).
How long does a 510(k) take for product code DIO?
Across 145 cleared submissions the average was 117 days from receipt to decision (median 80).
Which companies have the most DIO clearances?
Syva Co. (9); Roche Diagnostic Systems, Inc. (9); Princeton BioMeditech Corp. (7); Abbott Laboratories (6); Guangzhou Wondfo Biotech Co., Ltd. (4).
Have DIO devices been recalled?
Yes: 23 product recalls across 11 recall events; the most recent began 2020-08-18.
Next steps
- Run an FDA pathway report with predicate devices for product code DIO
- Run a recall and safety report across every DIO manufacturer
- Watch product code DIO for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Toxicology product codes · FDA product code lookup · 510(k) database search · 510(k) review times